Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ranjit Manchanda

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Gynecologic Oncology|October 8, 2024
The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN studyZheng Yuan Ng, Ranjit Manchanda, Aldo Lopez, et al.
Journal of Medical Genetics|December 23, 2024
The NHS England Jewish BRCA Testing Programme: overview after first year of implementation (2023-2024)Bethany Torr, Nicola Bell, Ruth McCarthy, et al.
British Journal of Cancer|September 30, 2024
BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trialBethany Torr, Christopher Jones, Grace Kavanaugh, et al.
Journal of Medical Genetics|November 21, 2022
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: <i>RAD51C</i>, <i>RAD51D</i>, <i>BRIP1</i> and <i>PALB2</i>Helen Hanson, Anjana Kulkarni, Lucy Loong, et al.
Cancers|May 21, 2020
Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and PreventionFaiza Gaba, Oleg Blyuss, Xinting Liu, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 27, 2023
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort studyMonika Sobocan, Dhivya Chandrasekaran, Michail Sideris, et al.
Journal of Medical Genetics|November 1, 2022
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in <i>BRCA1</i> and <i>BRCA2</i>Sue Philpott, Maria Raikou, Ranjit Manchanda, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancerSamuel Oxley, Sarah Ahmed, Kathryn Baxter, et al.
European Journal of Cancer (Oxford, England : 1990)|May 6, 2026
ESGO Consensus Statement on endometrial cancer prevention, risk reduction strategies, and management of women with Lynch syndromeClaudia Marchetti, Murat Gultekin, Carolina Maria Sassu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 5, 2021
Concise Reporting of Benign Endometrial Biopsies is an Acceptable Alternative to Descriptive ReportingDivya Kriplani, Ana A Olivar, Nairi Tchrakian, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Gynecologic Oncology|October 8, 2024
The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN studyZheng Yuan Ng, Ranjit Manchanda, Aldo Lopez, et al.
Journal of Medical Genetics|December 23, 2024
The NHS England Jewish BRCA Testing Programme: overview after first year of implementation (2023-2024)Bethany Torr, Nicola Bell, Ruth McCarthy, et al.
British Journal of Cancer|September 30, 2024
BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trialBethany Torr, Christopher Jones, Grace Kavanaugh, et al.
Journal of Medical Genetics|November 21, 2022
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: <i>RAD51C</i>, <i>RAD51D</i>, <i>BRIP1</i> and <i>PALB2</i>Helen Hanson, Anjana Kulkarni, Lucy Loong, et al.
Cancers|May 21, 2020
Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and PreventionFaiza Gaba, Oleg Blyuss, Xinting Liu, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 27, 2023
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort studyMonika Sobocan, Dhivya Chandrasekaran, Michail Sideris, et al.
Journal of Medical Genetics|November 1, 2022
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in <i>BRCA1</i> and <i>BRCA2</i>Sue Philpott, Maria Raikou, Ranjit Manchanda, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancerSamuel Oxley, Sarah Ahmed, Kathryn Baxter, et al.
European Journal of Cancer (Oxford, England : 1990)|May 6, 2026
ESGO Consensus Statement on endometrial cancer prevention, risk reduction strategies, and management of women with Lynch syndromeClaudia Marchetti, Murat Gultekin, Carolina Maria Sassu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 5, 2021
Concise Reporting of Benign Endometrial Biopsies is an Acceptable Alternative to Descriptive ReportingDivya Kriplani, Ana A Olivar, Nairi Tchrakian, et al.
Pageof 14